RARE DISEASES A–Z · LETTER D

Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is the most common and most severe of the childhood muscular dystrophies. Boys are born healthy but make no dystrophin — the protein that protects muscle fibres from damage — so muscle is gradually lost from early childhood, including, in time, the heart and the breathing muscles.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Duchenne muscular dystrophy is the severe childhood muscle disease caused by absent dystrophin, affecting boys. Weakness starts before age five and the heart and breathing muscles weaken later. Steroids, heart protection, and newer gene-targeted treatments slow it.

The guide

The basics

Duchenne is caused by changes in the dystrophin gene — the largest known human gene — on the X chromosome, so it almost always affects boys. Without dystrophin, muscle fibres are damaged by ordinary activity and progressively replaced by fat and scar tissue. Signs appear between ages two and five: late walking, frequent falls, difficulty running and climbing stairs, and a characteristic way of pushing up from the floor using the hands on the thighs (Gower's sign). Calves look enlarged but are weak. Walking is usually lost in the early teens. Later, the breathing muscles and heart weaken — cardiomyopathy is expected — and curvature of the spine can develop once walking stops. Learning and behaviour difficulties affect a minority, because dystrophin also has roles in the brain.

How it works

A blood creatine kinase level is massively raised in Duchenne — often tens of times normal — even before symptoms, making it a powerful first test in a boy with delayed motor milestones. Genetic testing of the dystrophin gene confirms the diagnosis and identifies the exact change, which matters because some newer treatments apply only to specific mutation types. Muscle biopsy is rarely needed now. At diagnosis the team also checks heart function (ECG and imaging), plans vaccination and bone health, and offers carrier testing and genetic counselling to the family — mothers and sisters may be carriers, with implications for their own heart health and future pregnancies.

Day to day

Daily steroid tablets (glucocorticoids) are the backbone of treatment and slow the disease — prolonging walking, protecting the heart and breathing, and reducing spinal surgery. Newer options include a weekly steroid designed to reduce side effects, and mutation-specific treatments: 'exon-skipping' injections that coax the gene to produce a shorter, partly working dystrophin in boys with suitable deletions, and a gene therapy delivering a mini-dystrophin gene, available in some countries for young boys. Heart-protective medicines start before symptoms, typically by around age ten. Physiotherapy, stretching, orthotics, and later powered mobility maintain function and independence; night-time ventilation supports breathing when needed. Bone protection, weight management, and psychological support complete the standard package.

When to get help

Care is coordinated by a neuromuscular centre following international care standards, with scheduled reviews of strength, spine, heart, breathing, nutrition, and bone health. Parents are taught the danger signs: chest infections need early treatment, and anaesthetists must know the diagnosis before any surgery because certain anaesthetic gases and muscle relaxants can be dangerous in Duchenne. Transition to adult services should be planned in the teens. Support organisations for Duchenne families are experienced and practical, and clinical trial registries are worth discussing, as eligibility often depends on age, mutation, and walking status — timing matters.

See a doctor promptly if: A chest infection, new breathlessness, or needing to sit up to breathe in someone with Duchenne needs prompt treatment — breathing muscles are weak and infections escalate fast.

Common questions

How did my son get Duchenne when nobody in the family has it?

It usually starts with carrier testing of the mother: about two-thirds of mothers of an affected boy are carriers, but in the remaining third the gene change arose new in the child. A genetic counsellor works through who in the family should be offered testing, including sisters.

Do steroids really help?

Steroids are the one treatment proven to slow Duchenne: boys treated with daily steroids typically walk years longer and develop less heart and breathing trouble. The trade-offs — weight gain, behaviour changes, bone thinning — are managed by the team and reviewed regularly.

Can girls have Duchenne?

Girls are usually carriers only, because their second X chromosome makes enough dystrophin. Rarely, a girl can be affected — for example with certain chromosome rearrangements — and some carriers develop heart problems, which is why carriers get heart checks too.

What is the outlook now?

Survival has improved steadily with steroids, heart protection, and breathing support: many men with Duchenne now live into their 30s and beyond, and plan education, work, and independent living accordingly. Care is increasingly adult-focused as a result.

More in Letter D

Related

Sources

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Steroid, heart, and breathing care are individual; follow your neuromuscular centre's plan for your child.